European Archives - Page 519 of 1010 - European Medical Journal

Continue
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
5 Mins
13 Oct 2020

Precision Medicine in NAFLD: Are We There Yet?

PRESENTING at an interactive session entitled ‘Precision medicine for the management of NAFLD – Are we there yet?’ at The Digital…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13 Oct 2020

FIB-4 and APRI Scores Revalidation in a Cohort Study of 69,106 Chronic Hepatitis C Patients

Assessment of liver fibrosis is vital for enabling therapeutic decisions and prognostic evaluation of chronic hepatitis…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13 Oct 2020

Progress in Hepatitis C Testing as Part of the Hepatitis C Elimination Programme in Georgia

In April 2015, the country of Georgia, with a high prevalence of hepatitis C virus (HCV) infection (5.4% of the adult population, approximately 150,000 persons), embarked on the world’s first national HCV Elimination programme…
3 Mins
13 Oct 2020

ILC Congress Interview: Prof Christian Trautwein

Prof Christian Trautwein | European Association for the Study of the Liver (EASL) Ethics Committee ChairpersonThe Department of Gastroenterology…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13 Oct 2020

Multivariant Surface Quasispecies in a Hepatitis B Virus Chronically Infected Individual with Concomitant and Continually Positive Surface Antigen and Anti-Hbs Biomarkers

Coexistence of hepatitis B virus (HBV) surface antigen (HBsAg) and antibodies (anti-HBs) can be found in 2.3–5.2% of chronic HBV (CHB) infected individuals…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13 Oct 2020

Contrast-Enhanced Ultrasound Algorithms for the Noninvasive Diagnosis of Hepatocellular Carcinoma in High-Risk Patients - A Prospective Multicentre Study (DEGUM CEUS HCC Trial)

Hepatocellular carcinoma (HCC) can be diagnosed noninvasively in high-risk patients by means of contrast-enhanced imaging…
Cardiology CP
8 Mins
12 Oct 2020

High-Density Lipoproteins and Cardiovascular Disease

For >20 years, clinical trials have consistently demonstrated that the reduction of levels of low-density lipoprotein (LDL) cholesterol results in lower cardiovascular event rates, in both the primary and secondary prevention setting…
9 Oct 2020

Maternal Faecal Microbiota Transplantation Restores Gut Microbiota in Caesarean-Born Infants

MICROBIOTA of the gut, which have a profound influence on the host’s body functions, can be restored through faecal transplantation in infants born through caesarean section (C-section).
9 Oct 2020

Multiple Sclerosis Medication Effectively Inhibits SARS-CoV-2 Replication In Vitro

REPLICATION of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to be inhibited by an antiviral medication approved in the treatment against multiple sclerosis in vitro.
9 Oct 2020

EMJ Podcast: The Learning Never Stops

This week, Jonathan reflects on the importance of Continuous Medical Education for healthcare professionals.